Zepbound and Wegovy are both FDA-approved weekly injections for chronic weight management — but they work differently, produce different results, and cost differently in 2026. Zepbound (tirzepatide) averages 22.5% weight loss over 72 weeks. Wegovy (semaglutide 2.4 mg) averages 14.9% over 68 weeks. A newer Wegovy option — Wegovy HD at 7.2 mg — closes much of that gap at 20.7%. This guide compares both drugs across every relevant dimension so you can find which is better for your goals.
Key takeaways
- Zepbound produces more weight loss than standard Wegovy — 22.5% vs 14.9% on average.
- Wegovy HD (7.2 mg) narrows the gap significantly, averaging 20.7%.
- Both drugs reduce belly fat, cardiovascular risk, and blood sugar.
- Zepbound costs less out of pocket for self-pay: $299/month vs $349/month for Wegovy starter doses.
- Both cost as little as $25/month with commercial insurance and a manufacturer savings card.
- Zepbound is a dual GLP-1 + GIP agonist. Wegovy is a GLP-1 agonist only. The added GIP action is why Zepbound wins on weight loss.
- The Wegovy pill (oral semaglutide 25 mg) offers a needle-free alternative starting at $149/month.
- Side effects are similar. Neither drug is “harder to tolerate”
- Switching between the two is possible — specific rules apply.
What is the difference between Wegovy and Zepbound?
The core difference between Wegovy and Zepbound is the mechanism.
Wegovy contains semaglutide, a GLP-1 receptor agonist. GLP-1 is a gut hormone that tells the brain you’re full, slows stomach emptying, and reduces appetite. Wegovy was FDA-approved for weight loss in June 2021.
Zepbound contains tirzepatide, a dual GLP-1 and GIP receptor agonist. GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that amplifies the GLP-1 signal, improves insulin sensitivity, and increases energy expenditure. Adding GIP on top of GLP-1 is the reason Zepbound produces greater weight loss than Wegovy at standard doses.
Think of it this way: Wegovy operates one hunger-control pathway. Zepbound operates two simultaneously. Same destination — significantly different results.
| Zepbound | Wegovy (2.4 mg) | Wegovy HD (7.2 mg) | |
|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide | Semaglutide |
| Mechanism | GLP-1 + GIP | GLP-1 only | GLP-1 only |
| FDA approval | Nov 2023 | Jun 2021 | Mar 2026 |
| Dosing | Once weekly | Once weekly | Once weekly |
| Average weight loss | 22.5% | 14.9% | 20.7% |
| Self-pay starter price | $299/month | $349/month | ~$399/month |
| With savings card | $25/month | $25/month | $25/month |
| Manufacturer | Eli Lilly | Novo Nordisk | Novo Nordisk |
Wegovy vs Zepbound weight loss comparison
This is the question that matters most. Both are effective. The data is clear on which produces more.
Zepbound (SURMOUNT-1, 72 weeks, 2,539 adults without diabetes):
- Average weight loss: 22.5% at 15 mg
- 91% lost at least 5% of body weight
- 79% lost at least 10%
- 65% lost at least 15%
- 49% lost at least 20%
Wegovy — semaglutide 2.4 mg (STEP 1, 68 weeks, 1,961 adults without diabetes):
- Average weight loss: 14.9%
- 87% lost at least 5%
- 69% lost at least 10%
- 48% lost at least 15%
- 28% lost at least 20%
Wegovy HD — semaglutide 7.2 mg (STEP UP, 72 weeks, 1,407 adults without diabetes):
- Average weight loss: 20.7%
- 89% lost at least 5%
- 79% lost at least 10%
- 65% lost at least 15%
- 49% lost at least 20%
Figure 1. Zepbound vs Wegovy weight loss milestones: % of patients reaching each threshold at 72–68 weeks. Sources: SURMOUNT-1 (NEJM 2022), STEP 1 (NEJM 2021), STEP UP (Lancet D&E, 2025).
The chart makes the comparison concrete. At the ≥20% milestone, Zepbound and Wegovy HD are neck-and-neck (49% each). Standard Wegovy trails significantly at 28%. For most people, Zepbound or Wegovy HD are the stronger options if maximum weight loss is the goal.
Is Zepbound better than Wegovy for weight loss? At standard doses, yes. At the highest doses — Zepbound 15 mg vs Wegovy HD 7.2 mg — the difference largely disappears. If you cannot tolerate the titration to Wegovy HD, Zepbound is the clearer choice for greater weight loss.
Zepbound vs Wegovy cost in 2026
Cost is often the deciding factor. Here’s the full picture.
Self-pay pricing (no insurance)
| Zepbound | Wegovy (injection) | Wegovy pill | |
|---|---|---|---|
| Starter dose | $299/month (2.5 mg) | $349/month (0.25 mg) | $149/month (1.5 mg) |
| Mid-dose | $399/month (5 mg) | $349/month (starter range) | — |
| Maintenance dose | $449/month (7.5–15 mg) | $349–$399/month (2.4 mg) | ~$449/month (25 mg) |
| Highest dose available | $449/month (15 mg) | ~$399/month (7.2 mg HD) | ~$449/month (25 mg) |
Zepbound self-pay is cheaper than Wegovy at most dose levels. Zepbound vials ship through LillyDirect for $299–$449/month. Wegovy vials through NovoCare start at $349/month.
With insurance and savings cards
Both drugs cost as little as $25/month with commercial insurance and the manufacturer savings card. The eligibility rules are the same: commercial (non-government) insurance, US residency, valid prescription.
Neither savings card works with Medicare, Medicaid, TRICARE, or VA. See our dedicated guides:
Medicare coverage
Neither Zepbound nor Wegovy is covered by Medicare Part D for weight loss. Medicare can cover Mounjaro (same drug as Zepbound) for type 2 diabetes, and Ozempic (same drug as Wegovy) for type 2 diabetes. The Medicare GLP-1 Bridge starting July 1, 2026 may expand this — check current CMS guidance for updates.
Wegovy vs Zepbound dosage chart
Both drugs use a slow titration to reduce nausea and improve tolerance. The schedules are different.
Zepbound dosage schedule
| Weeks | Dose |
|---|---|
| 1–4 | 2.5 mg weekly |
| 5–8 | 5 mg weekly |
| 9–12 | 7.5 mg weekly |
| 13–16 | 10 mg weekly |
| 17–20 | 12.5 mg weekly |
| 21+ | 15 mg weekly (max dose) |
Tirzepatide titrates in 2.5 mg steps over 20 weeks. Most patients reach 10–15 mg for maintenance.
Wegovy dosage schedule
| Weeks | Dose |
|---|---|
| 1–4 | 0.25 mg weekly |
| 5–8 | 0.5 mg weekly |
| 9–12 | 1.0 mg weekly |
| 13–16 | 1.7 mg weekly |
| 17+ | 2.4 mg weekly (standard max) |
| 21+ | 7.2 mg weekly (Wegovy HD, optional) |
Semaglutide titrates more slowly in smaller steps. Standard max is 2.4 mg. Wegovy HD 7.2 mg requires at least 4 weeks at 2.4 mg first.
Full dosing details: semaglutide dosing guidelines.
Side effects: Zepbound vs Wegovy difference
The side effect profiles are nearly identical — this makes sense because both drugs work through the same GLP-1 pathway. The most common reactions are gastrointestinal and occur mainly during dose escalation.
| Side effect | Zepbound | Wegovy |
|---|---|---|
| Nausea | 28% | 44% |
| Diarrhea | 22% | 30% |
| Vomiting | 13% | 24% |
| Constipation | 17% | 24% |
| Discontinuation due to side effects | 6.2% | 6.9% |
Wegovy shows slightly higher GI rates, possibly because semaglutide more potently slows gastric emptying through the GLP-1 pathway alone. Zepbound’s GIP component may counterbalance some of this effect.
Both drugs carry the same boxed warning for thyroid C-cell tumors (seen in animal studies) and are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2).
Neither drug is objectively “harder to tolerate” — discontinuation rates are nearly the same (6.2% vs 6.9%). Individual tolerance varies.
Wegovy pill vs Zepbound injection: a different kind of comparison
The Wegovy pill (oral semaglutide 25 mg) launched in January 2026. It opened a new comparison: injectable Zepbound vs oral Wegovy.
| Wegovy pill | Zepbound injection | |
|---|---|---|
| Form | Daily oral tablet | Weekly injection |
| Average weight loss | 13.6–16.6% (OASIS 4, 64 weeks) | 22.5% (SURMOUNT-1, 72 weeks) |
| Food restriction | 30-min fast before taking | None |
| Refrigeration | Not required | Required (up to 28 days at room temp) |
| Self-pay price | $149/month (starter) | $299/month (starter) |
| Best for | Needle-avoiders, lower cost entry | Maximum weight loss |
Zepbound injection produces meaningfully more weight loss. The Wegovy pill wins on convenience and price — and it’s the better choice for anyone who wants an oral option or is on a tighter budget. See our full Wegovy pill vs injection comparison for more.
Which is better — Wegovy or Zepbound?
There’s no universal answer, but there are clear patterns.
Zepbound is likely better if:
- Maximum weight loss is the priority
- You have type 2 diabetes alongside obesity (tirzepatide has a stronger glucose-lowering effect)
- You want the lower self-pay price ($299 vs $349 starter)
- Your insurance covers Zepbound
Wegovy 2.4 mg is likely better if:
- You want the drug with the longer real-world track record (approved 2021 vs 2023)
- You need cardiovascular risk reduction as a primary indication (Wegovy has the SELECT trial supporting this)
- Your insurance covers Wegovy but not Zepbound
Wegovy HD 7.2 mg is better if:
- You’ve been on 2.4 mg for at least 4 weeks and want more weight loss
- Your results on standard Wegovy have plateaued
- You’re comfortable with a higher dose and its slightly higher side effect profile
Wegovy pill is better if:
- You want to avoid injections entirely
- Budget is a priority ($149/month starter)
- Moderate weight loss (13–16%) is sufficient
Switching from Wegovy to Zepbound — or the other way
Switching from Wegovy to Zepbound
Switching is straightforward. Stop semaglutide injections and start tirzepatide the following week. Most providers start at 2.5 mg tirzepatide regardless of what dose of Wegovy you were on — the molecules are different enough that dose equivalence doesn’t directly translate.
Expect a brief re-titration period of 4–8 weeks before you reach a comparable maintenance dose.
Switching from Zepbound to Wegovy
Same approach. Stop tirzepatide and start semaglutide the following week, starting at 0.25 mg and re-titrating through the standard Wegovy schedule. Full re-titration takes about 16 weeks.
Why switch at all?
Common reasons: insurance changes (coverage switches from one drug to the other), cost, tolerance differences, or a provider recommendation based on results. Some patients also switch to trial the Wegovy pill for oral convenience after achieving initial weight loss on an injectable.
Always discuss switching with your prescribing provider before making the change. Book a free Heally consultation if you want to talk through the switch with a licensed physician.
Conclusion
Both Zepbound and Wegovy are highly effective FDA-approved weight loss medications. Zepbound produces more weight loss at standard doses — 22.5% vs 14.9% on average. Wegovy HD closes the gap considerably at 20.7%. Both cost $25/month with commercial insurance. Zepbound is cheaper without insurance.
The difference between Wegovy and Zepbound isn’t a simple “one is better” answer. It’s about which drug fits your body, your budget, your insurance, and your goals. Zepbound edges ahead on raw weight loss numbers. Wegovy has a longer track record and a proven cardiovascular benefit.
If you’re unsure which to start, a licensed provider can match the right option to your full medical picture. Book a free consultation with Heally — same-day telehealth appointments in 40+ states.
FAQ
Is Zepbound better than Wegovy for weight loss?
At standard doses, yes. Zepbound (tirzepatide 15 mg) averages 22.5% weight loss vs Wegovy’s (semaglutide 2.4 mg) 14.9%. However, Wegovy HD at 7.2 mg narrows the gap to 20.7% — nearly matching Zepbound. The answer depends on which dose of Wegovy you compare.
What is the difference between Wegovy and Zepbound?
Wegovy contains semaglutide, a GLP-1 receptor agonist. Zepbound contains tirzepatide, a dual GLP-1 and GIP receptor agonist. The added GIP action in Zepbound produces stronger appetite suppression and greater average weight loss at standard doses.
Which is cheaper — Zepbound or Wegovy?
Zepbound is cheaper for self-pay patients. LillyDirect sells Zepbound vials at $299/month for the 2.5 mg starter dose, vs $349/month for Wegovy through NovoCare. With commercial insurance and a savings card, both cost as little as $25/month. The Wegovy pill is cheaper still at $149/month but produces less weight loss.
Can you switch from Wegovy to Zepbound?
Yes. Stop Wegovy on your regular injection day, then start Zepbound 2.5 mg the following week. Re-titrate through the standard tirzepatide schedule. Most providers recommend starting at 2.5 mg regardless of your prior Wegovy dose.
Can you switch from Zepbound to Wegovy?
Yes. Stop Zepbound on your regular injection day, then start Wegovy 0.25 mg the following week. Re-titrate through the standard semaglutide schedule over about 16 weeks.
Is the Wegovy pill better than Zepbound?
For convenience and cost, the Wegovy pill wins — $149/month starter, no injections, no refrigeration. For weight loss, Zepbound wins — 22.5% average vs 13.6–16.6% for the pill. The right choice depends on whether you prioritize ease of use or maximum results.
Do Wegovy and Zepbound have the same side effects?
Mostly yes. Both cause nausea, diarrhea, constipation, and vomiting during dose escalation. Both carry the same thyroid tumor warning. Wegovy shows slightly higher rates of GI side effects in trials. Discontinuation rates are nearly identical: 6.9% for Wegovy, 6.2% for Zepbound.
Which drug has better insurance coverage — Wegovy or Zepbound?
It depends on your specific plan. Wegovy has been on more formularies longer (approved 2021 vs 2023). Some plans that cover Wegovy don’t yet cover Zepbound, and vice versa. Always check your plan’s formulary for both drugs before assuming one is covered.
Does Medicare cover Wegovy or Zepbound?
No. Medicare Part D currently cannot cover either drug for weight loss. Wegovy is covered for cardiovascular risk reduction in eligible patients. Medicare can cover Ozempic (same drug as Wegovy) and Mounjaro (same drug as Zepbound) for type 2 diabetes.
What’s the difference between Zepbound and Mounjaro, and Wegovy and Ozempic?
Zepbound and Mounjaro both contain tirzepatide — Zepbound is approved for weight loss, Mounjaro for type 2 diabetes. Wegovy and Ozempic both contain semaglutide — Wegovy for weight loss, Ozempic for type 2 diabetes. Same drug, different labels and indications.
Related reading on Heally:
- Semaglutide vs tirzepatide: key differences, efficacy, and which is right for you
- What is Wegovy HD? A complete 2026 guide to the 7.2 mg semaglutide injection
- How much does Zepbound cost in 2026? A complete pricing guide
- Wegovy pills vs injection: a complete comparison guide for 2026
- What to eat on Wegovy: a 2026 diet guide and meal plan
Sources
- Jastreboff AM et al. — Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) (NEJM, 2022)
- Wilding JPH et al. — Once-weekly semaglutide in adults with overweight or obesity (STEP 1) (NEJM, 2021)
- Wadden TA et al. — STEP UP trial: semaglutide 7.2 mg for obesity (Lancet Diabetes & Endocrinology, 2025)
- Lincoff AM et al. — Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT trial) (NEJM, 2023)
- FDA — Zepbound (tirzepatide) prescribing information
- FDA — Wegovy (semaglutide) prescribing information, 2025
- Novo Nordisk — Wegovy pill (oral semaglutide 25 mg) FDA approval, December 2025
- Eli Lilly — LillyDirect Zepbound self-pay pricing
Medical disclaimer: This article is for informational purposes only. Results from clinical trials may differ from real-world outcomes. Always consult a licensed healthcare provider before starting, switching, or stopping any prescription weight loss medication. Individual results vary.